{"transactions":[{"id":4266118,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":174665,"kind":"person","name":"SCHLACHET DAVID","position":1,"cik":"0001235445","reported_name":"SCHLACHET DAVID","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase Common Shares","published_at":"2017-07-06T00:22:45.000Z","date":"2017-07-01","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Will become exercisable in four equal quarterly installments after the date of grant on July 1, 2017 based upon continued service on the board of directors."}],"balance_after":20000,"derivative":{"exercise_price":3.15,"expiration_date":"2022-06-30","underlying":"Common Shares","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-17-043813","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/876343/000120919117043813/doc4.xml","form_type":"4"}}]}